BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 38081962)

  • 1. The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention.
    Lyu Y; Xie F; Chen B; Shin WS; Chen W; He Y; Leung KT; Tse GMK; Yu J; To KF; Kang W
    Oncogene; 2024 Jan; 43(2):77-91. PubMed ID: 38081962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ion channels in gastrointestinal cancer.
    Anderson KJ; Cormier RT; Scott PM
    World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.
    Nautiyal J; Kanwar SS; Majumdar AP
    Curr Protein Pept Sci; 2010 Sep; 11(6):436-50. PubMed ID: 20491625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastrointestinal microbiota and its role in oncogenesis.
    Lam SY; Yu J; Wong SH; Peppelenbosch MP; Fuhler GM
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):607-618. PubMed ID: 29566903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant RNA m
    Shen LT; Che LR; He Z; Lu Q; Chen DF; Qin ZY; Wang B
    Cell Death Dis; 2023 Apr; 14(4):236. PubMed ID: 37015927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
    Karakasheva TA; Lin EW; Tang Q; Qiao E; Waldron TJ; Soni M; Klein-Szanto AJ; Sahu V; Basu D; Ohashi S; Baba K; Giaccone ZT; Walker SR; Frank DA; Wileyto EP; Long Q; Dunagin MC; Raj A; Diehl JA; Wong KK; Bass AJ; Rustgi AK
    Cancer Res; 2018 Sep; 78(17):4957-4970. PubMed ID: 29976575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights.
    Rauth S; Malafa M; Ponnusamy MP; Batra SK
    Gastroenterology; 2024 May; ():. PubMed ID: 38759843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers.
    Sun Y; Wang R; Qiao M; Xu Y; Guan W; Wang L
    J Cell Physiol; 2018 Sep; 233(9):6359-6369. PubMed ID: 29334123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Features of Tumor Microenvironment: A Genetic Spotlight.
    Asadi M; Zarredar H; Zafari V; Soleimani Z; Saeedi H; Caner A; Shanehbandi D
    Cell Biochem Biophys; 2024 Mar; 82(1):107-118. PubMed ID: 37870699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerves in gastrointestinal cancer: from mechanism to modulations.
    Vaes N; Idris M; Boesmans W; Alves MM; Melotte V
    Nat Rev Gastroenterol Hepatol; 2022 Dec; 19(12):768-784. PubMed ID: 36056202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nervous System Contributes to the Tumorigenesis and Progression of Human Digestive Tract Cancer.
    Dai D; Liu H
    J Immunol Res; 2022; 2022():9595704. PubMed ID: 35295188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research Progress in Immunosuppressive Tumor Microenvironment of Gastrointestinal Cancer].
    Li YT; Tan XY; Huang LN; Ma LX; Fu L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):7-14. PubMed ID: 35048593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
    Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers.
    Akbari A; Majd HM; Rahnama R; Heshmati J; Morvaridzadeh M; Agah S; Amini SM; Masoodi M
    Biomed Pharmacother; 2020 Nov; 131():110729. PubMed ID: 33152911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the immune milieu in gastrointestinal cancers.
    Turkes F; Mencel J; Starling N
    J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastrointestinal tumor microenvironment.
    Quante M; Varga J; Wang TC; Greten FR
    Gastroenterology; 2013 Jul; 145(1):63-78. PubMed ID: 23583733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.
    Chu YD; Chen CW; Lai MW; Lim SN; Lin WR
    World J Gastroenterol; 2023 Aug; 29(29):4499-4527. PubMed ID: 37621758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.